NCT07528040Not yet recruiting
An Observational, Multicenter Study to Evaluate the Effectiveness of Guselkumab for the Treatment of Participants With Crohn's Disease After Surgical Resection
Source: ClinicalTrials.gov · Last updated 14 Apr 2026
Brief summary (registry, in English)
The goal of this single arm ,non-interventional, prospective, descriptive study is to evaluate the efficacy of guselkumab treatment in preventing endoscopic recurrence of Crohn's Disease in adult participants who have a documented diagnosis of moderate to severe CD and have undergone an ileocolonic surgical resection. The primary endpoint is Endoscopic recurrence rate at week24.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 88 (estimated)
- First submitted
- 7 Apr 2026
- Start date
- 15 Apr 2026
- Primary completion date
- 31 Dec 2028
- Lead sponsor
- Shanghai 10th People's Hospital
- Diseases
- Crohn's disease
- NCT number
- NCT07528040
What you commit to
- Study type: Observational
- Planned participants: 88
- From 15 Apr 2026 to the primary completion date, 31 Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Has complications of CD, such as short bowel syndrome Currently has or is suspected to have an abscess
- Active infection
- Currently has a malignancy or has a history of malignancy within 5 years
Who the study is looking for
- Patients≥ 18，
- Have a documented diagnosis of moderate to severe CD
- Have undergone an ileocolonic surgical resection
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Shanghai 10th People's Hospital, Tongji University School of Medicine Coordinator of this site? Confirm its status | Shanghai | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.